These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 12485905)

  • 1. Multiple degradation pathways for Fos family proteins.
    Acquaviva C; Bossis G; Ferrara P; Brockly F; Jariel-Encontre I; Piechaczyk M
    Ann N Y Acad Sci; 2002 Nov; 973():426-34. PubMed ID: 12485905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degradation of cellular and viral Fos proteins.
    Acquaviva C; Ferrara P; Bossis G; Brockly F; Salvat C; Jariel-Encontre I; Piechaczyk M
    Biochimie; 2001; 83(3-4):357-62. PubMed ID: 11295497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evasion from proteasomal degradation by mutated Fos proteins expressed from FBJ-MSV and FBR-MSV osteosarcomatogenic retroviruses.
    Acquaviva C; Bossis G; Ferrara P; Brockly F; Jariel-Encontre I; Piechaczyk M
    Biochem Pharmacol; 2002 Sep; 64(5-6):957-61. PubMed ID: 12213592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and viral Fos proteins are degraded by different proteolytic systems.
    Acquaviva C; Salvat C; Brockly F; Bossis G; Ferrara P; Piechaczyk M; Jariel-Encontre I
    Oncogene; 2001 Feb; 20(8):942-50. PubMed ID: 11314029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The structural determinants responsible for c-Fos protein proteasomal degradation differ according to the conditions of expression.
    Ferrara P; Andermarcher E; Bossis G; Acquaviva C; Brockly F; Jariel-Encontre I; Piechaczyk M
    Oncogene; 2003 Mar; 22(10):1461-74. PubMed ID: 12629509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complex mechanisms for c-fos and c-jun degradation.
    Jariel-Encontre I; Salvat C; Steff AM; Pariat M; Acquaviva C; Furstoss O; Piechaczyk M
    Mol Biol Rep; 1997 Mar; 24(1-2):51-6. PubMed ID: 9228281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential directing of c-Fos and c-Jun proteins to the proteasome in serum-stimulated mouse embryo fibroblasts.
    Salvat C; Jariel-Encontre I; Acquaviva C; Omura S; Piechaczyk M
    Oncogene; 1998 Jul; 17(3):327-37. PubMed ID: 9690514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a C-terminal tripeptide motif involved in the control of rapid proteasomal degradation of c-Fos proto-oncoprotein during the G(0)-to-S phase transition.
    Acquaviva C; Brockly F; Ferrara P; Bossis G; Salvat C; Jariel-Encontre I; Piechaczyk M
    Oncogene; 2001 Nov; 20(51):7563-72. PubMed ID: 11709728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-Fos proto-oncoprotein is degraded by the proteasome independently of its own ubiquitinylation in vivo.
    Bossis G; Ferrara P; Acquaviva C; Jariel-Encontre I; Piechaczyk M
    Mol Cell Biol; 2003 Oct; 23(20):7425-36. PubMed ID: 14517309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are there multiple proteolytic pathways contributing to c-Fos, c-Jun and p53 protein degradation in vivo?
    Salvat C; Aquaviva C; Jariel-Encontre I; Ferrara P; Pariat M; Steff AM; Carillo S; Piechaczyk M
    Mol Biol Rep; 1999 Apr; 26(1-2):45-51. PubMed ID: 10363646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitinylation of transcription factors c-Jun and c-Fos using reconstituted ubiquitinylating enzymes.
    Hermida-Matsumoto ML; Chock PB; Curran T; Yang DC
    J Biol Chem; 1996 Mar; 271(9):4930-6. PubMed ID: 8617766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degradation of the proto-oncogene product c-Fos by the ubiquitin proteolytic system in vivo and in vitro: identification and characterization of the conjugating enzymes.
    Stancovski I; Gonen H; Orian A; Schwartz AL; Ciechanover A
    Mol Cell Biol; 1995 Dec; 15(12):7106-16. PubMed ID: 8524278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degradation of c-Fos by the 26S proteasome is accelerated by c-Jun and multiple protein kinases.
    Tsurumi C; Ishida N; Tamura T; Kakizuka A; Nishida E; Okumura E; Kishimoto T; Inagaki M; Okazaki K; Sagata N
    Mol Cell Biol; 1995 Oct; 15(10):5682-7. PubMed ID: 7565719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated ERK-MAP kinase activity protects the FOS family member FRA-1 against proteasomal degradation in colon carcinoma cells.
    Vial E; Marshall CJ
    J Cell Sci; 2003 Dec; 116(Pt 24):4957-63. PubMed ID: 14625389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquitin-independent- versus ubiquitin-dependent proteasomal degradation of the c-Fos and Fra-1 transcription factors: is there a unique answer?
    Basbous J; Jariel-Encontre I; Gomard T; Bossis G; Piechaczyk M
    Biochimie; 2008 Feb; 90(2):296-305. PubMed ID: 17825471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clastosome: a subtype of nuclear body enriched in 19S and 20S proteasomes, ubiquitin, and protein substrates of proteasome.
    Lafarga M; Berciano MT; Pena E; Mayo I; Castaño JG; Bohmann D; Rodrigues JP; Tavanez JP; Carmo-Fonseca M
    Mol Biol Cell; 2002 Aug; 13(8):2771-82. PubMed ID: 12181345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Fos phosphorylation induced by H2O2 prevents proteasomal degradation of c-Fos in cardiomyocytes.
    Coronella-Wood J; Terrand J; Sun H; Chen QM
    J Biol Chem; 2004 Aug; 279(32):33567-74. PubMed ID: 15136564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Fos degradation by the proteasome. An early, Bcl-2-regulated step in apoptosis.
    He H; Qi XM; Grossmann J; Distelhorst CW
    J Biol Chem; 1998 Sep; 273(39):25015-9. PubMed ID: 9737957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Fos degradation by the ubiquitin-proteasome proteolytic pathway in osteoclast progenitors.
    Ito Y; Inoue D; Kido S; Matsumoto T
    Bone; 2005 Dec; 37(6):842-9. PubMed ID: 16172035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitin-independent proteasomal degradation of Fra-1 is antagonized by Erk1/2 pathway-mediated phosphorylation of a unique C-terminal destabilizer.
    Basbous J; Chalbos D; Hipskind R; Jariel-Encontre I; Piechaczyk M
    Mol Cell Biol; 2007 Jun; 27(11):3936-50. PubMed ID: 17371847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.